Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 861177 NEW YORK, NY

Position in HRTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$893
-$769 QoQ
Shares Held
2,078
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#138
of 160 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. HRTX ranks #194 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $893 2,078
2026-03-31 $1,662 2,078
2023-06-30 $128,470 110,752
2023-03-31 $167,233 110,752
2022-12-31 $276,878 110,752
2022-09-30 $467,370 110,752
2022-06-30 $308,996 110,752
2022-03-31 $633,499 110,752
2021-12-31 $1,013,501 111,008
2021-09-30 $1,046,966 97,939
2021-06-30 $1,604,454 103,380
2021-03-31 $1,597,801 98,569
2020-12-31 $1,998,404 94,398
2020-09-30 $1,398,976 94,398
2020-06-30 $1,325,722 90,124
2020-03-31 $1,068,830 91,042